Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Estimates Beat
|
Expensive Star
6452.5000
-127.50
(
-1.94
%)
NSE
May 20, 2025
15:31 PM
New 52W High in past week
Volume:
448.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
17 Nov 2020
Estimates Beat
6452.50
-1.94%
Divis Laboratories Limited
Divi's Laboratories Ltd.
by
SMC online
SMC online
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - May 20, 2025
The Baseline |
20 May 2025, 05:40PM
Market closes lower, Hindalco Industries's Q4 net profit beats Forecaster estimates by 24%
Trendlyne Marketwatch |
20 May 2025, 04:00PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022